J Korean Med Sci.  2021 Nov;36(44):e283. 10.3346/jkms.2021.36.e283.

The Waiting List Mortality of Pediatric Heart Transplantation Candidates in Korea before the Pediatric Ventricular Assist Device Era

Affiliations
  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 2Department of Pediatrics, Asan Medical Center, Seoul, Korea
  • 3Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea

Abstract

Background
Despite advancements in heart transplantation for pediatric patients in Korea, the waiting list mortality has not been reported. Therefore, we investigated the waiting list mortality rate and factors associated with patient mortality.
Methods
We reviewed the medical records of pediatric patients who were registered for heart transplantation at three major hospitals in Korea from January 2000 to January 2020. All patients who died while waiting for heart transplantation were investigated, and we identified the waiting list mortality rate, causes of mortality and the median survival periods depending on the variable risk factors.
Results
A total of 145 patients received heart transplantations at the three institutions we surveyed, and the waiting list mortality rate was 26%. The most common underlying diseases were cardiomyopathy (66.7%) and congenital heart disease (30.3%). The leading causes that contributed to death were heart failure (36.3%), multi-organ failure (27.2%), and complications associated with extracorporeal membrane oxygenation (ECMO) (25.7%). The median survival period was 63 days. ECMO was applied in 30 patients. The different waiting list mortality percentages according to age, cardiac diagnosis, use of ECMO, and initial Korean Network of Organ Sharing (KONOS) level were determined using univariate analysis, but age was the only significant factor associated with waiting list mortality based on a multivariate analysis.
Conclusion
The waiting list mortality of pediatric heart transplantation candidates was confirmed to be considerably high, and age, underlying disease, the application of ECMO, and the initial KONOS level were the factors that influenced the survival period.

Keyword

Heart Transplantation; Pediatrics; Waiting Lists; Mortality

Figure

  • Fig. 1 A flow diagram illustrating the patient selection process.HT = heart transplantation, KONOS = Korean Network of Organ Sharing.

  • Fig. 2 The Kaplan-Meier survival curve of the waiting list mortality group.

  • Fig. 3 A comparison of cumulative survival curves depending on various risk factors. (A) By patient age, (B) use of ECMO, (C) the initial KONOS level, (D) cardiac diagnosis.ECMO = extracorporeal membrane oxygenation, KONOS = Korean Network of Organ Sharing, CMP = cardiomyopathy.


Reference

1. Almond CS, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009; 119(5):717–727. PMID: 19171850.
Article
2. Shimizu M, Nishinaka T, Inai K, Nakanishi T. Outcomes in children with advanced heart failure in Japan: importance of mechanical circulatory support. Heart Vessels. 2016; 31(7):1162–1167. PMID: 26243029.
Article
3. Smits JM, Thul J, De Pauw M, Delmo Walter E, Strelniece A, Green D, et al. Pediatric heart allocation and transplantation in Eurotransplant. Transpl Int. 2014; 27(9):917–925. PMID: 24853064.
Article
4. Mah D, Singh TP, Thiagarajan RR, Gauvreau K, Piercey GE, Blume ED, et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009; 28(12):1292–1298. PMID: 19782580.
Article
5. Jeewa A, Manlhiot C, Kantor PF, Mital S, McCrindle BW, Dipchand AI. Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list. J Thorac Cardiovasc Surg. 2014; 147(1):462–468. PMID: 24183905.
Article
6. Zafar F, Castleberry C, Khan MS, Mehta V, Bryant R 3rd, Lorts A, et al. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices. J Heart Lung Transplant. 2015; 34(1):82–88. PMID: 25447574.
Article
7. Kim YH. Pediatric heart transplantation: how to manage problems affecting long-term outcomes? Clin Exp Pediatr. 2021; 64(2):49–59. PMID: 33233874.
Article
8. McGiffin DC, Naftel DC, Kirklin JK, Morrow WR, Towbin J, Shaddy R, et al. Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. J Heart Lung Transplant. 1997; 16(7):713–722. PMID: 9257253.
9. Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. J Heart Lung Transplant. 1997; 16(12):1255–1266. PMID: 9436138.
10. Nield LE, McCrindle BW, Bohn DJ, West LJ, Coles JG, Freedom RM, et al. Outcomes for children with cardiomyopathy awaiting transplantation. Cardiol Young. 2000; 10(4):358–366. PMID: 10950333.
Article
11. Mital S, Addonizio LJ, Lamour JM, Hsu DT. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant. 2003; 22(2):147–153. PMID: 12581762.
Article
12. Chen JM, Weinberg AD, Rose EA, Thompson SM, Mancini DM, Ellison JP, et al. Multivariate analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg. 1996; 61(2):570–575. PMID: 8572769.
Article
13. Jeewa A, Manlhiot C, McCrindle BW, Van Arsdell G, Humpl T, Dipchand AI. Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation. Artif Organs. 2010; 34(12):1087–1091. PMID: 20545660.
Article
14. Cassidy J, Dominguez T, Haynes S, Burch M, Kirk R, Hoskote A, et al. A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device--the United Kingdom experience. J Heart Lung Transplant. 2013; 32(11):1101–1106. PMID: 24060499.
Article
15. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D'Alessandro A, Dec GW, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation. 2002; 106(7):836–841. PMID: 12176957.
16. Henderson HT, Canter CE, Mahle WT, Dipchand AI, LaPorte K, Schechtman KB, et al. ABO-incompatible heart transplantation: analysis of the Pediatric Heart Transplant Study (PHTS) database. J Heart Lung Transplant. 2012; 31(2):173–179. PMID: 22305379.
Article
17. Khushnood A, Butt TA, Jungschleger J, Henderson P, Smith JH, De Rita F, et al. Paediatric donation after circulatory determined death heart transplantation using donor normothermic regional perfusion and ex situ heart perfusion: a case report. Pediatr Transplant. 2019; 23(6):e13536. PMID: 31273913.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr